Rescue from excitotoxicity and axonal degeneration accompanied by age-dependent behavioral and neuroanatomical alterations in caspase-6-deficient mice

Human Molecular Genetics

Volumn 21, Issue 9, 2012, Pages 1954-1967

  Uribe, Valeria ^a   Wong, Bibiana K Y ^a   Graham, Rona K ^a   Cusack, Corey L ^b   Skotte, Niels H ^a,c   Pouladi, Mahmoud A ^a   Xie, Yuanyun ^a   Feinberg, Konstantin ^d   Ou, Yimiao ^d   Ouyang, Yingbin ^g   Deng, Yu ^a   Franciosi, Sonia ^a   Bissada, Nagat ^a   Spreeuw, Amanda ^a   Zhang, Weining ^a   Ehrnhoefer, Dagmar E ^a   Vaid, Kuljeet ^a   Miller, Freda D ^d,e   Deshmukh, Mohanish ^b   Howland, David ^f   Hayden, Michael R ^a   more..

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d HOSPITAL FOR SICK CHILDREN   (Canada)

^e UNIVERSITY OF TORONTO   (Canada)

^f CHDI MANAGEMENT CHDI FOUNDATION   (United States)

^g Taconic Farms Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 6; MESSENGER RNA; MYELIN;

AGE DISTRIBUTION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BEHAVIOR; BODY WEIGHT; BRAIN CORTEX; BRAIN DEVELOPMENT; BRAIN FUNCTION; BRAIN SIZE; CONTROLLED STUDY; EXCITOTOXICITY; LEARNING DISORDER; MOUSE; NERVE FIBER DEGENERATION; NERVE GROWTH; NEUROANATOMY; NONHUMAN; OPEN FIELD TEST; PHENOTYPE; PHYSIOLOGY; PRIORITY JOURNAL; PROTEIN ANALYSIS; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ROTAROD TEST; STEREOLOGY; STRIATE CORTEX;

AGING; ALZHEIMER DISEASE; ANIMALS; APOPTOSIS; BASE SEQUENCE; BEHAVIOR, ANIMAL; BRAIN; CASPASE 6; HUMANS; HUNTINGTON DISEASE; MICE; MICE, KNOCKOUT; MOTOR ACTIVITY; NERVE DEGENERATION; NEURONS; RECEPTORS, N-METHYL-D-ASPARTATE; RNA, MESSENGER;

MUS;

EID: 84859244583     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/dds005     Document Type: Article

References (98)

1. Arends, M.J. and Wyllie, A.H. (1991) Apoptosis: mechanisms and roles in pathology. Int. Rev. Exp. Pathol., 32, 223-254.
2. Ellis, R.E., Yuan, J.Y. and Horvitz, H.R. (1991) Mechanisms and functions of cell death. Annu. Rev. Cell Biol., 7, 663-698.
3. Zheng, T.S. and Flavell, R.A. (1999) Apoptosis. All's well that ends dead. Nature, 400, 410-411.
4. Zheng, T.S., Hunot, S., Kuida, K. and Flavell, R.A. (1999) Caspase knockouts: matters of life and death. Cell Death Differ., 6, 1043-1053.
5. Raff, M.C., Barres, B.A., Burne, J.F., Coles, H.S., Ishizaki, Y. and Jacobson, M.D. (1993) Programmed cell death and the control of cell survival: lessons from the nervous system. Science, 262, 695-700.
6. Troy, C.M. and Salvesen, G.S. (2002) Caspases on the brain. J. Neurosci. Res., 69, 145-150.
7. De Maria, R., Zeuner, A., Eramo, A., Domenichelli, C., Bonci, D., Grignani, F., Srinivasula, S.M., Alnemri, E.S., Testa, U. and Peschle, C. (1999) Negative regulation of erythropoiesis by caspase-mediated cleavage of GATA-1. Nature, 401, 489-493.
8. Kennedy, N., Kataoka, T., Tschopp, J. and Budd, R.C. (1999) Caspase activation is required for T cell proliferation. J. Exp. Med., 190, 1725-1728.
9. Li, Z., Jo, J., Jia, J.-M., Lo, S.-C., Whitcomb, D.J., Jiao, S., Cho, K. and Sheng, M. (2010) Caspase-3 activation via mitochondria is required for long-term depression and AMPA receptor internalization. Cell, 141, 859-871.
10. Fischer, U., Jänicke, R.U. and Schulze-Osthoff, K. (2003) Many cuts to ruin: a comprehensive update of caspase substrates. Cell Death Differ., 10, 76-100.
11. Dash, P.K., Blum, S. and Moore, A.N. (2000) Caspase activity plays an essential role in long-term memory. Neuroreport, 11, 2811-2816.
12. Nicholson, D.W. (1999) Caspase structure, proteolytic substrates, and function during apoptotic cell death. Cell Death Differ., 6, 1028-1042.
13. Albrecht, S., Bogdanovic, N., Ghetti, B., Winblad, B. and LeBlanc, A.C. (2009) Caspase-6 activation in familial Alzheimer disease brains carrying amyloid precursor protein or presenilin I or presenilin II mutations. J. Neuropathol. Exp. Neurol., 68, 1282-1293.
14. Graham, R.K., Deng, Y., Carroll, J., Vaid, K., Cowan, C., Pouladi, M.A., Metzler, M., Bissada, N., Wang, L., Faull, R.L.M. et al. (2010) Cleavage at the 586 amino acid caspase-6 site in mutant huntingtin influences caspase-6 activation in vivo. J. Neurosci., 30, 15019-15029.
15. Hermel, E., Gafni, J., Propp, S.S., Leavitt, B.R., Wellington, C.L., Young, J.E., Hackam, A.S., Logvinova, A.V., Peel, A.L., Chen, S.F. et al. (2004) Specific caspase interactions and amplification are involved in selective neuronal vulnerability in Huntington's disease. Cell Death Differ., 11, 424-438.
16. Slee, E.A., Harte, M.T., Kluck, R.M., Wolf, B.B., Casiano, C.A., Newmeyer, D.D., Wang, H.G., Reed, J.C., Nicholson, D.W., Alnemri, E.S. et al. (1999) Ordering the cytochrome c-initiated caspase cascade: hierarchical activation of caspases-2, -3, -6, -7, -8, and -10 in a caspase-9-dependent manner. J. Cell Biol., 144, 281-292.
17. D'Amelio, M., Cavallucci, V., Middei, S., Marchetti, C., Pacioni, S., Ferri, A., Diamantini, A., De Zio, D., Carrara, P., Battistini, L. et al. (2011) Caspase-3 triggers early synaptic dysfunction in a mouse model of Alzheimer's disease. Nat. Neurosci., 14, 69-76.
18. Zhang, J., Gorostiza, O.F., Tang, H., Bredesen, D.E. and Galvan, V. (2010) Reversal of learning deficits in hAPP transgenic mice carrying a mutation at Asp664: a role for early experience. Behav. Brain Res., 206, 202-207.
19. Gervais, F.G., Xu, D., Robertson, G.S., Vaillancourt, J.P., Zhu, Y., Huang, J., LeBlanc, A., Smith, D., Rigby, M., Shearman, M.S. et al. (1999) Involvement of caspases in proteolytic cleavage of Alzheimer's amyloid-beta precursor protein and amyloidogenic A beta peptide formation. Cell, 97, 395-406.
20. Albrecht, S., Bourdeau, M., Bennett, D., Mufson, E.J., Bhattacharjee, M. and LeBlanc, A.C. (2007) Activation of caspase-6 in aging and mild cognitive impairment. Am. J. Pathol., 170, 1200-1209.
21. Kubodera, T., Yokota, T., Ohwada, K., Ishikawa, K., Miura, H., Matsuoka, T. and Mizusawa, H. (2003) Proteolytic cleavage and cellular toxicity of the human alpha1A calcium channel in spinocerebellar ataxia type 6. Neurosci. Lett., 341, 74-78.
22. Haacke, A., Broadley, S.A., Boteva, R., Tzvetkov, N., Hartl, F.U. and Breuer, P. (2006) Proteolytic cleavage of polyglutamine-expanded ataxin-3 is critical for aggregation and sequestration of non-expanded ataxin-3. Hum. Mol. Genet., 15, 555-568.
23. Akpan, N., Serrano-Saiz, E., Zacharia, B.E., Otten, M.L., Ducruet, A.F., Snipas, S.J., Liu, W., Velloza, J., Cohen, G., Sosunov, S.A. et al. (2011) Intranasal delivery of caspase-9 inhibitor reduces caspase-6-dependent axon/neuron loss and improves neurological function after stroke. J. Neurosci., 31, 8894-8904.
24. Galvan, V., Gorostiza, O.F., Banwait, S., Ataie, M., Logvinova, A.V., Sitaraman, S., Carlson, E., Sagi, S.A., Chevallier, N., Jin, K. et al. (2006) Reversal of Alzheimer's-like pathology and behavior in human APP transgenic mice by mutation of Asp664. Proc. Natl Acad. Sci. USA, 103, 7130-7135.
25. Galvan, V., Zhang, J., Gorostiza, O.F., Banwait, S., Huang, W., Ataie, M., Tang, H. and Bredesen, D.E. (2008) Long-term prevention of Alzheimer's disease-like behavioral deficits in PDAPP mice carrying a mutation in Asp664. Behav. Brain Res., 191, 246-255.
26. Saganich, M.J., Schroeder, B.E., Galvan, V., Bredesen, D.E., Koo, E.H. and Heinemann, S.F. (2006) Deficits in synaptic transmission and learning in amyloid precursor protein (APP) transgenic mice require C-terminal cleavage of APP. J. Neurosci., 26, 13428-13436.
27. Nguyen, T.-V.V., Galvan, V., Huang, W., Banwait, S., Tang, H., Zhang, J. and Bredesen, D.E. (2008) Signal transduction in Alzheimer disease: p21-activated kinase signaling requires C-terminal cleavage of APP at Asp664. J. Neurochem., 104, 1065-1080.
28. Banwait, S., Galvan, V., Zhang, J., Gorostiza, O.F., Ataie, M., Huang, W., Crippen, D., Koo, E.H. and Bredesen, D.E. (2008) C-terminal cleavage of the amyloid-beta protein precursor at Asp664: a switch associated with Alzheimer's disease. J. Alzheimers Dis., 13, 1-16.
29. Bredesen, D.E., John, V. and Galvan, V. (2010) Importance of the caspase cleavage site in amyloid-beta protein precursor. J. Alzheimers Dis., 22, 57-63.
30. Harris, J.A., Devidze, N., Halabisky, B., Lo, I., Thwin, M.T., Yu, G.Q., Bredesen, D.E., Masliah, E. and Mucke, L. (2010) Many neuronal and behavioral impairments in transgenic mouse models of Alzheimer's disease are independent of caspase cleavage of the amyloid precursor protein. J. Neurosci., 30, 372-381.
31. Nikolaev, A., McLaughlin, T., O'Leary, D.D.M. and Tessier-Lavigne, M. (2009) APP binds DR6 to trigger axon pruning and neuron death via distinct caspases. Nature, 457, 981-989.
32. Graham, R.K., Deng, Y., Slow, E.J., Haigh, B., Bissada, N., Lu, G., Pearson, J., Shehadeh, J., Bertram, L., Murphy, Z. et al. (2006) Cleavage at the caspase-6 site is required for neuronal dysfunction and degeneration due to mutant huntingtin. Cell, 125, 1179-1191.
33. Tebbenkamp, A.T., Green, C., Xu, G., Denovan-Wright, E.M., Rising, A.C., Fromholt, S.E., Brown, H.H., Swing, D., Mandel, R.J., Tessarollo, L. et al. (2011) Transgenic mice expressing caspase-6-derived N-terminal fragments of mutant huntingtin develop neurologic abnormalities with predominant cytoplasmic inclusion pathology composed largely of a smaller proteolytic derivative. Hum. Mol. Genet., 20, 2770-2782.
34. Pouladi, M.A., Graham, R.K., Karasinska, J.M., Xie, Y., Santos, R.D., Petersén, A. and Hayden, M.R. (2009) Prevention of depressive behaviour in the YAC128 mouse model of Huntington disease by mutation at residue 586 of huntingtin. Brain, 132, 919-932.
35. Milnerwood, A.J., Gladding, C.M., Pouladi, M.A., Kaufman, A.M., Hines, R.M., Boyd, J.D., Ko, R.W.Y., Vasuta, O.C., Graham, R.K., Hayden, M.R. et al. (2010) Early increase in extrasynaptic NMDA receptor signaling and expression contributes to phenotype onset in Huntington's disease mice. Neuron, 65, 178-190.
36. Metzler, M., Gan, L., Mazarei, G., Graham, R.K., Liu, L., Bissada, N., Lu, G., Leavitt, B.R. and Hayden, M.R. (2010) Phosphorylation of huntingtin at Ser421 in YAC128 neurons is associated with protection of YAC128 neurons from NMDA-mediated excitotoxicity and is modulated by PP1 and PP2A. J. Neurosci., 30, 14318-14329.
37. Leyva, M.J., Degiacomo, F., Kaltenbach, L.S., Holcomb, J., Zhang, N., Gafni, J., Park, H., Lo, D.C., Salvesen, G.S., Ellerby, L.M. et al. (2010) Identification and evaluation of small molecule pan-caspase inhibitors in Huntington's disease models. Chem. Biol., 17, 1189-1200.
38. O'Brien, T. and Lee, D. (2004) Prospects for caspase inhibitors. Mini Rev. Med. Chem., 4, 153-165.
39. Park, K.J., Grosso, C.A., Aubert, I., Kaplan, D.R. and Miller, F.D. (2010) p75NTR-dependent, myelin-mediated axonal degeneration regulates neural connectivity in the adult brain. Nat. Neurosci., 13, 559-566.
40. Fernandes-Alnemri, T., Litwack, G. and Alnemri, E.S. (1995) Mch2, a new member of the apoptotic Ced-3/Ice cysteine protease gene family. Cancer Res., 55, 2737-2742.
41. Raff, M.C., Whitmore, A.V. and Finn, J.T. (2002) Axonal self-destruction and neurodegeneration. Science, 296, 868-871.
42. Buss, R.R., Sun, W. and Oppenheim, R.W. (2006) Adaptive roles of programmed cell death during nervous system development. Annu. Rev. Neurosci., 29, 1-35.
43. Singh, K.K., Park, K.J., Hong, E.J., Kramer, B.M., Greenberg, M.E., Kaplan, D.R. and Miller, F.D. (2008) Developmental axon pruning mediated by BDNF-p75NTR-dependent axon degeneration. Nat. Neurosci., 11, 649-658.
44. Luo, L. and O'Leary, D.D.M. (2005) Axon retraction and degeneration in development and disease. Annu. Rev. Neurosci., 28, 127-156.
45. Rosas, H.D., Lee, S.Y., Bender, A.C., Zaleta, A.K., Vangel, M., Yu, P., Fischl, B., Pappu, V., Onorato, C., Cha, J.H., Salat, D.H. and Hersch, S.M. (2010) Altered white matter microstructure in the corpus callosum in Huntington's disease: implications for cortical disconnection. Neuroimage, 49, 2995-3004.
46. Dumas, E.M., van den Bogaard, S.J., Ruber, M.E., Reilman, R.R., Stout, J.C., Craufurd, D., Hicks, S.L., Kennard, C., Tabrizi, S.J., van Buchem, M.A. et al. (2011) Early changes in white matter pathways of the sensorimotor cortex in premanifest Huntington's disease. Hum. Brain Mapp., 33, 203-212.
47. Salat, D.H., Greve, D.N., Pacheco, J.L., Quinn, B.T., Helmer, K.G., Buckner, R.L. and Fischl, B. (2009) Regional white matter volume differences in nondemented aging and Alzheimer's disease. Neuroimage, 44, 1247-1258.
48. Varfolomeev, E.E., Schuchmann, M., Luria, V., Chiannilkulchai, N., Beckmann, J.S., Mett, I.L., Rebrikov, D., Brodianski, V.M., Kemper, O.C., Kollet, O. et al. (1998) Targeted disruption of the mouse Caspase 8 gene ablates cell death induction by the TNF receptors, Fas/Apo1, and DR3 and is lethal prenatally. Immunity, 9, 267-276.
49. Kuida, K., Haydar, T.F., Kuan, C.Y., Gu, Y., Taya, C., Karasuyama, H., Su, M.S., Rakic, P. and Flavell, R.A. (1998) Reduced apoptosis and cytochrome c-mediated caspase activation in mice lacking caspase 9. Cell, 94, 325-337.
50. Hakem, R., Hakem, A., Duncan, G.S., Henderson, J.T., Woo, M., Soengas, M.S., Elia, A., de la Pompa, J.L., Kagi, D., Khoo, W. et al. (1998) Differential requirement for caspase 9 in apoptotic pathways in vivo. Cell, 94, 339-352.
51. Houde, C., Banks, K.G., Coulombe, N., Rasper, D., Grimm, E., Roy, S., Simpson, E.M. and Nicholson, D.W. (2004) Caspase-7 expanded function and intrinsic expression level underlies strain-specific brain phenotype of caspase-3-null mice. J. Neurosci., 24, 9977-9984.
52. Paulsen, J.S., Nopoulos, P.C., Aylward, E., Ross, C.A., Johnson, H., Magnotta, V.A., Juhl, A., Pierson, R.K., Mills, J., Langbehn, D. et al. (2010) Striatal and white matter predictors of estimated diagnosis for Huntington disease. Brain Res. Bull., 82, 201-207.
53. Carroll, J.B., Lerch, J.P., Franciosi, S., Spreeuw, A., Bissada, N., Henkelman, R.M. and Hayden, M.R. (2011) Natural history of disease in the YAC128 mouse reveals a discrete signature of pathology in Huntington disease. Neurobiol. Dis., 43, 257-265.
54. Dawson, H.N., Cantillana, V., Jansen, M., Wang, H., Vitek, M.P., Wilcock, D.M., Lynch, J.R. and Laskowitz, D.T. (2010) Loss of tau elicits axonal degeneration in a mouse model of Alzheimer's disease. Neuroscience, 169, 516-531.
55. Jawhar, S., Trawicka, A., Jenneckens, C., Bayer, T.A. and Wirths, O. (2010) Motor deficits, neuron loss, and reduced anxiety coinciding with axonal degeneration and intraneuronal Abeta aggregation in the 5XFAD mouse model of Alzheimer's disease. Neurobiol. Aging, 33, e29-e40.
56. Sivananthan, S.N., Lee, A.W., Goodyer, C.G. and LeBlanc, A.C. (2010) Familial amyloid precursor protein mutants cause caspase-6-dependent but amyloid b-peptide-independent neuronal degeneration in primary human neuron cultures. Cell Death Dis., 1, e100.
57. Levine, M.S., Klapstein, G.J., Koppel, A., Gruen, E., Cepeda, C., Vargas, M.E., Jokel, E.S., Carpenter, E.M., Zanjani, H., Hurst, R.S. et al. (1999) Enhanced sensitivity to N-methyl-D-aspartate receptor activation in transgenic and knockin mouse models of Huntington's disease. J. Neurosci. Res., 58, 515-532.
58. Zeron, M.M., Hansson, O., Chen, N., Wellington, C.L., Leavitt, B.R., Brundin, P., Hayden, M.R. and Raymond, L.A. (2002) Increased sensitivity to N-methyl-D-aspartate receptor-mediated excitotoxicity in a mouse model of Huntington's disease. Neuron, 33, 849-860.
59. Graham, R.K., Slow, E.J., Deng, Y., Bissada, N., Lu, G., Pearson, J., Shehadeh, J., Leavitt, B.R., Raymond, L.A. and Hayden, M.R. (2006) Levels of mutant huntingtin influence the phenotypic severity of Huntington disease in YAC128 mouse models. Neurobiol. Dis., 21, 444-455.
60. Zeron, M.M., Fernandes, H.B., Krebs, C., Shehadeh, J., Wellington, C.L., Leavitt, B.R., Baimbridge, K.G., Hayden, M.R. and Raymond, L.A. (2004) Potentiation of NMDA receptor-mediated excitotoxicity linked with intrinsic apoptotic pathway in YAC transgenic mouse model of Huntington's disease. Mol. Cell. Neurosci., 25, 469-479.
61. Slow, E.J., van Raamsdonk, J., Rogers, D., Coleman, S.H., Graham, R.K., Deng, Y., Oh, R., Bissada, N., Hossain, S.M., Yang, Y.-Z. et al. (2003) Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease. Hum. Mol. Genet., 12, 1555-1567.
62. Van Raamsdonk, J.M., Pearson, J., Slow, E.J., Hossain, S.M., Leavitt, B.R. and Hayden, M.R. (2005) Cognitive dysfunction precedes neuropathology and motor abnormalities in the YAC128 mouse model of Huntington's disease. J. Neurosci., 25, 4169-4180.
63. Hsia, A.Y., Masliah, E., McConlogue, L., Yu, G.Q., Tatsuno, G., Hu, K., Kholodenko, D., Malenka, R.C., Nicoll, R.A. and Mucke, L. (1999) Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models. Proc. Natl Acad. Sci. USA, 96, 3228-3233.
64. Troy, C.M., Akpan, N. and Jean, Y.Y. (2011) Regulation of caspases in the nervous system implications for functions in health and disease. Prog. Mol. Biol. Transl. Sci., 99, 265-305.
65. LeBlanc, A., Liu, H., Goodyer, C., Bergeron, C. and Hammond, J. (1999) Caspase-6 role in apoptosis of human neurons, amyloidogenesis, and Alzheimer's disease. J. Biol. Chem., 274, 23426-23436.
66. Henshall, D.C., Skradski, S.L., Meller, R., Araki, T., Minami, M., Schindler, C.K., Lan, J.Q., Bonislawski, D.P. and Simon, R.P. (2002) Expression and differential processing of caspases 6 and 7 in relation to specific epileptiform EEG patterns following limbic seizures. Neurobiol. Dis., 10, 71-87.
67. Narkilahti, S. and Pitkänen, A. (2005) Caspase 6 expression in the rat hippocampus during epileptogenesis and epilepsy. Neuroscience, 131, 887-897.
68. Nguyen, N., Lee, S.B., Lee, Y.S., Lee, Y.S., Lee, K.-H. and Ahn, J.-Y. (2009) Neuroprotection by NGF and BDNF against neurotoxin-exerted apoptotic death in neural stem cells are mediated through Trk receptors, activating PI3-kinase and MAPK pathways. Neurochem. Res., 34, 942-951.
69. Yu, L.-Y., Saarma, M. and Arumäe, U. (2008) Death receptors and caspases but not mitochondria are activated in the GDNF- or BDNF-deprived dopaminergic neurons. J. Neurosci., 28, 7467-7475.
70. Nguyen, T.L., Kim, C.K., Cho, J.H., Lee, K.H. and Ahn, J.Y. (2010) Neuroprotection signaling pathway of nerve growth factor and brain-derived neurotrophic factor against staurosporine induced apoptosis in hippocampal H19-7/IGF-IR [corrected]. Exp. Mol. Med., 42, 583-595.
71. Abidin, I., Eysel, U.T., Lessmann, V. and Mittmann, T. (2008) Impaired GABAergic inhibition in the visual cortex of brain-derived neurotrophic factor heterozygous knockout mice. J. Physiol. (Lond.), 586, 1885-1901.
72. Tanaka, J.-I., Horiike, Y., Matsuzaki, M., Miyazaki, T., Ellis-Davies, G.C.R. and Kasai, H. (2008) Protein synthesis and neurotrophin-dependent structural plasticity of single dendritic spines. Science, 319, 1683-1687.
73. Poo, M.M. (2001) Neurotrophins as synaptic modulators. Nat. Rev. Neurosci., 2, 24-32.
74. Panagiotaki, N., Dajas-Bailador, F., Amaya, E., Papalopulu, N. and Dorey, K. (2010) Characterisation of a new regulator of BDNF signalling, Sprouty3, involved in axonal morphogenesis in vivo. Development, 137, 4005-4015.
75. Gross, I., Armant, O., Benosman, S., de Aguilar, J.L., Freund, J.N., Kedinger, M., Licht, J.D., Gaiddon, C. and Loeffler, J.P. (2007) Sprouty2 inhibits BDNF-induced signaling and modulates neuronal differentiation and survival. Cell Death Differ., 14, 1802-1812.
76. Gorski, J.A., Zeiler, S.R., Tamowski, S. and Jones, K.R. (2003) Brain-derived neurotrophic factor is required for the maintenance of cortical dendrites. J. Neurosci., 23, 6856-6865.
77. Bekinschtein, P., Cammarota, M., Izquierdo, I. and Medina, J.H. (2008) BDNF and memory formation and storage. Neuroscientist, 14, 147-156.
78. Bekinschtein, P., Cammarota, M., Katche, C., Slipczuk, L., Rossato, J.I., Goldin, A., Izquierdo, I. and Medina, J.H. (2008) BDNF is essential to promote persistence of long-term memory storage. Proc. Natl Acad. Sci. USA, 105, 2711-2716.
79. Rauskolb, S., Zagrebelsky, M., Dreznjak, A., Deogracias, R., Matsumoto, T., Wiese, S., Erne, B., Sendtner, M., Schaeren-Wiemers, N., Korte, M. et al. (2010) Global deprivation of brain-derived neurotrophic factor in the CNS reveals an area-specific requirement for dendritic growth. J. Neurosci., 30, 1739-1749.
80. Ricobaraza, A., Cuadrado-Tejedor, M., Marco, S., Perez-Otano, I. and Garcia-Osta, A. (2010) Phenylbutyrate rescues dendritic spine loss associated with memory deficits in a mouse model of Alzheimer disease. Hippocampus. [Epub ahead of print].
81. Shirayama, Y., Chen, A.C.-H., Nakagawa, S., Russell, D.S. and Duman, R.S. (2002) Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression. J. Neurosci., 22, 3251-3261.
82. Eisch, A.J., Bolaños, C.A., de Wit, J., Simonak, R.D., Pudiak, C.M., Barrot, M., Verhaagen, J. and Nestler, E.J. (2003) Brain-derived neurotrophic factor in the ventral midbrain-nucleus accumbens pathway: a role in depression. Biol. Psychiatry, 54, 994-1005.
83. Berton, O., McClung, C.A., Dileone, R.J., Krishnan, V., Renthal, W., Russo, S.J., Graham, D., Tsankova, N.M., Bolanos, C.A., Rios, M. et al. (2006) Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress. Science, 311, 864-868.
84. Bazzu, G., Calia, G., Puggioni, G., Spissu, Y., Rocchitta, G., Debetto, P., Grigoletto, J., Zusso, M., Migheli, R., Serra, P.A., Desole, M.S. and Miele, E. (2010) Alpha-synuclein-and MPTP-generated rodent models of Parkinsons disease and the study of extracellular striatal dopamine dynamics: a microdialysis approach. CNS Neurol. Disord. Drug Targets, 9, 482-490.
85. Aggleton, J.P., Keen, S., Warburton, E.C. and Bussey, T.J. (1997) Extensive cytotoxic lesions involving both the rhinal cortices and area TE impair recognition but spare spatial alternation in the rat. Brain Res. Bull., 43, 279-287.
86. Liu, P. and Bilkey, D.K. (2001) The effect of excitotoxic lesions centered on the hippocampus or perirhinal cortex in object recognition and spatial memory tasks. Behav. Neurosci., 115, 94-111.
87. Brown, M.W. and Aggleton, J.P. (2001) Recognition memory: what are the roles of the perirhinal cortex and hippocampus? Nat. Rev. Neurosci., 2, 51-61.
88. Xiang, J.Z. and Brown, M.W. (1999) Differential neuronal responsiveness in primate perirhinal cortex and hippocampal formation during performance of a conditional visual discrimination task. Eur. J. Neurosci., 11, 3715-3724.
89. Guo, H., Pétrin, D., Zhang, Y., Bergeron, C., Goodyer, C.G. and LeBlanc, A.C. (2006) Caspase-1 activation of caspase-6 in human apoptotic neurons. Cell Death Differ., 13, 285-292.
90. Zhang, L., Xing, Y., Ye, C.F., Ai, H.X., Wei, H.F. and Li, L. (2006) Learning-memory deficit with aging in APP transgenic mice of Alzheimer's disease and intervention by using tetrahydroxystilbene glucoside. Behav. Brain Res., 173, 246-254.
91. Tohda, C., Naito, R. and Joyashiki, E. (2008) Kihi-to, a herbal traditional medicine, improves Abeta(25-35)-induced memory impairment and losses of neurites and synapses. BMC Complement. Altern. Med., 8, 49.
92. Velloso, N.A., Dalmolin, G.D., Gomes, G.M., Rubin, M.A., Canas, P.M., Cunha, R.A. and Mello, C.F. (2009) Spermine improves recognition memory deficit in a rodent model of Huntington's disease. Neurobiol. Learn. Mem., 92, 574-580.
93. Jiang, C.H., Tsien, J.Z., Schultz, P.G. and Hu, Y. (2001) The effects of aging on gene expression in the hypothalamus and cortex of mice. Proc. Natl Acad. Sci. USA, 98, 1930-1934.
94. Wellington, C.L., Ellerby, L.M., Gutekunst, C.-A., Rogers, D., Warby, S., Graham, R.K., Loubser, O., van Raamsdonk, J., Singaraja, R., Yang, Y.-Z. et al. (2002) Caspase cleavage of mutant huntingtin precedes neurodegeneration in Huntington's disease. J. Neurosci., 22, 7862-7872.
95. Potts, P.R., Singh, S., Knezek, M., Thompson, C.B. and Deshmukh, M. (2003) Critical function of endogenous XIAP in regulating caspase activation during sympathetic neuronal apoptosis. J. Cell Biol., 163, 789-799.
96. Taylor, M.D., Holdeman, A.S., Weltmer, S.G., Ryals, J.M. and Wright, D.E. (2005) Modulation of muscle spindle innervation by neurotrophin-3 following nerve injury. Exp. Neurol., 191, 211-222.
97. Mayhew, T.M. and Olsen, D.R. (1991) Magnetic resonance imaging (MRI) and model-free estimates of brain volume determined using the Cavalieri principle. J. Anat., 178, 133-144.
98. Sonmez, O.F., Odaci, E., Bas, O., Colakoglu, S., Sahin, B., Bilgic, S. and Kaplan, S. (2010) A stereological study of MRI and the Cavalieri principle combined for diagnosis and monitoring of brain tumor volume. J. Clin. Neurosci., 17, 1499-1502.